PRIDEVIN M1

PRIDEVIN-M1

Composition

Metformin 500 mg Prolonged Release +Glimepiride 1 mg SMART TABLETS

Pack: 15 tablets/strip

DOSAGE: 1 to 2 Tablets / Day

The real-world evidence in the Indian clinical setting Indicates that Glimepiride and Metformin fixed-dose combinations are widely used in the management in T2DM patients with comorbidities like hypertension, dyslipidemia and diabetes complications. Glimepiride and Metformin fixed-dose combinations are suitable for early as well as long-standing diabetes.

Indication:

  • Not associated with hypoglycemia
  • No Weight Gain
  • Increased insulin sensitivity
  • Beneficial effects on Lipid profile (HDL-LDL)
  • Reduction in risk of stroke